UPDATE: Baird Starts Tracon Pharmaceuticals (TCON) at Outperform
Tweet Send to a Friend
(Updated - February 23, 2022 6:33 AM EST)
Baird analyst Joel Beatty initiates coverage on Tracon Pharmaceuticals (NASDAQ: TCON) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Joel Beatty initiates coverage on Tracon Pharmaceuticals (NASDAQ: TCON) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
